| pubmed-article:12626463 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12626463 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:12626463 | lifeskim:mentions | umls-concept:C0026272 | lld:lifeskim |
| pubmed-article:12626463 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:12626463 | lifeskim:mentions | umls-concept:C0069122 | lld:lifeskim |
| pubmed-article:12626463 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12626463 | pubmed:dateCreated | 2003-3-10 | lld:pubmed |
| pubmed-article:12626463 | pubmed:abstractText | Mixed connective tissue disease is an overlap syndrome characterized by features of different systemic autoimmune diseases and a high titer of U1-snRNP antibodies. We examine here the autoantibodies to nucleoporin p62 in a severe case of mixed connective tissue disease in a young male patient. Thus far, p62 antibodies have mainly been described in cases of primary biliary cirrhosis. We speculate that the presence of p62 antibodies is an indication of a poor prognosis in connective tissue disorders. | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12626463 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12626463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12626463 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12626463 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12626463 | pubmed:issn | 1071-412X | lld:pubmed |
| pubmed-article:12626463 | pubmed:author | pubmed-author:KneitzChristi... | lld:pubmed |
| pubmed-article:12626463 | pubmed:author | pubmed-author:TonyHans-Pete... | lld:pubmed |
| pubmed-article:12626463 | pubmed:author | pubmed-author:KraemerDoris... | lld:pubmed |
| pubmed-article:12626463 | pubmed:author | pubmed-author:KrausMichael... | lld:pubmed |
| pubmed-article:12626463 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12626463 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:12626463 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12626463 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12626463 | pubmed:pagination | 329-31 | lld:pubmed |
| pubmed-article:12626463 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:meshHeading | pubmed-meshheading:12626463... | lld:pubmed |
| pubmed-article:12626463 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12626463 | pubmed:articleTitle | Nucleoporin p62 antibodies in a case of mixed connective tissue disease. | lld:pubmed |
| pubmed-article:12626463 | pubmed:affiliation | Medizinische Poliklinik, University of Wurzburg, 97070 Wurzburg, Germany. d.kraemer@medizin.uni-wuerzburg.de | lld:pubmed |
| pubmed-article:12626463 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12626463 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:12626463 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12626463 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12626463 | lld:pubmed |
